Fonager et al.1
|
Denmark |
5.2 million |
1980-1997 |
Danish National Registry |
3,351 |
Gender analysis: Men 4 - 6 Women 3 - 4 |
60.4 |
1.32 |
NA |
30-d case fatality rate 23% |
Tleyjeh et al.2
|
USA (Olmsted County) |
1970 - 51 000 2000 - 90 000 |
1970-2000 |
Rochester Epidemiology Project |
107 |
5.0-7.0 |
61.5 (18.8-90.6) |
2.7 |
1 |
Valve surgery 15% 6 mo mortality 14-33% |
Sy et al.7
|
Australia (New South Wales) |
6.6 million |
2000-2006 |
Statewide database |
1,536 |
4.7 |
62 (42-75) |
1.8 |
15 |
Valve surgery 20% In Hospital mortality 14% 6 mo. mortality 18% |
Fedeli et al.8
|
Italy (Veneto region) |
4.8 million |
2000-2008 |
Electronic archives of hospital discharge records |
1,863 |
4.4 |
68 |
1.4 - 2 |
NA |
Valve surgery 23% In Hospital mortality 14.3% |
Selton-Suty et al.108
|
France (greater Paris, Lorraine, Rhone-Alpes, Franche-Comte´, Marne, Ille-et-Vilaine, and Languedoc-Roussillon) |
15.3 million |
2008 |
Case report forms sent to physicians likely to be in charge of IE cases |
497 |
3.2 |
62.3 |
2.8 |
5 |
Valve surgery 44.9% In-hospital mortality 22.7% |
Bikdeli et al.109
|
USA |
NA (inpatients >65 yrs. old) |
1999-2010 |
Medicare & Medicaid Services, Medicare inpatient Standard Analytic Files |
262,658 |
7.2 |
79 |
0.7-0.8 |
NA |
In hospital mortality 9-11% 30 d mortality – 14-16.5% 1 yr. mortality – 32.6-36.2% |
Duval et al.9
|
France (Greater Paris, Lorraine, and Rhône-Alpes) |
11 million |
1 yr. survey 1991, 1999 and 2008 |
Case report forms sent to physicians likely to be in charge of IE cases |
1991 - 323 1999 – 331 2008 - 339 |
1991 – 3.5 1999 – 3.3 2008 – 3.2 |
1991 – 57.9 1999 – 59.8 2008 – 61.6 |
1991 – 1.9 1999 – 2.3 2008 – 2.9 |
NA |
Valve surgery (1991 – 31.3%; 1999 – 50.2%; 2008 – 49.6%) In Hospital mortality (1991 – 20.7%; 1999 – 15.4%; 2008 – 21.2%) |
Ternhag et al.110
|
Sweden |
|
1997-2007 |
Swedish Hospital Discharge Register |
7,603 |
7.7 |
65.7 |
1.45 |
NA |
30-day mortality rate – 10.4% 1-5 yr. mortality rate – 14.7% |
Dayer et al.111
|
England |
NA |
2000-2013 |
Secondary Uses Service |
19,804 |
2.7 |
NA |
NA |
NA |
NA |
Pant et al.112
|
USA |
NA |
2000-2011 |
Nationwide Inpatient Sample database |
457,052 |
11-15 |
NA |
NA |
NA |
NA |
Erichsen et al.10
|
Denmark |
NA |
1994–2011 |
Danish nationwide registry |
5,486 |
7.55 (2009–2011) |
63 |
1.8 |
NA |
NA |
Keller et al.62
|
Germany |
80 million |
2005-2014 |
Nationwide database of the Federal Statistical Office of Germany |
94,364 |
11.6 |
NA |
NA |
NA |
In hospital mortality 17% |
Toyoda et al.11
|
USA (California and New York State) |
NA |
1998-2013 |
Statewide Planning and Research Cooperative System database (New York); Office of Statewide Health Planning and Development database (California) |
75,829 |
7.6 to 9.3 |
62.3 |
1.2 |
25 |
Valve surgery - 11-13% 90-day mortality – 24% |
Van der Brink et al.113
|
Netherlands |
NA |
2005-2011 |
Dutch Healthcare Authority |
5213 |
2005-3.0 2011- 6.3 |
66.4 |
2.3 |
9.3 |
All-cause mortality 36.1% |
Cresti et al.3
|
Italy (Grosseto) |
217778 |
1998-2014 |
Healthcare system database |
170 |
4.6 |
69.5 |
1.54 |
19 |
Valve surgery – 46% In hospital mortality 25% 1 yr. mortality 32% |
Ahtela et al.114
|
Finland |
NA |
2005-2014 |
Care Register for Health Care (CRHC) data- base |
2611 |
6.3 |
60.0 |
2.1 |
NA |
30 d mortality – 11% |
Olmos et al.97
|
Spain |
NA |
2003-2014 |
Spanish National Health System |
16867 |
2.7 in 2003 3.5 in 2014 per 100,000 person/year |
NA |
2 |
NA |
In hospital mortality rate 20% |
Shah et al.65
|
Scotland |
NA |
1990-2014 |
National hospitalization registry National microbiology register |
7638 |
5.3 in 1990 |
65 |
0.96 |
58 |
30-day outcome: All cause death – 9.6-17.3% Valve surgery – 3.8-6.3% 1-year outcome: All cause death – 27-33.3% Valve surgery – 9.2-15.5% |